Mangiferin reduces the levels of pro-inflammatory cytokines, pro-apoptotic proteins, and TGF-β, as well as the phosphorylation of p38, thereby alleviating myocardial fibrosis in rats with myocardial ischemia-reperfusion injury (208). This evidence concerns the gene TGFB1 and Myocardial fibrosis.